{"DataElement":{"publicId":"3440330","version":"1","preferredName":"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","preferredDefinition":"Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","longName":"3440200v1.0:3440297v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3440200","version":"1","preferredName":"Neoplasm Clinical N Stage","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"2404687v1.0:2428496v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2404687","version":"1","preferredName":"Neoplasm","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0094ACAF-11BC-1BCA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-12","modifiedBy":"ONEDATA","dateModified":"2005-09-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428496","version":"1","preferredName":"Clinical N Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0888-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE1C4AB1-4D83-EB7B-E040-BB89AD434E76","latestVersionIndicator":"Yes","beginDate":"2012-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for and approved by TCGA per T.Lichtenberg. mc 4/23/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3440297","version":"1","preferredName":"American Joint Committee on Cancer Clinical N Stage","preferredDefinition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3440297v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":"2","maxLength":"12","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N0","valueDescription":"N0 Stage Finding","ValueMeaning":{"publicId":"3202490","version":"1","preferredName":"N0 Stage Finding","longName":"3202490","preferredDefinition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N0 TNM Finding","conceptCode":"C48705","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0CF7-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9DA6-642A-E040-BB89AD435F64","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N0 (i+)","valueDescription":"N0 (i+) Stage Finding","ValueMeaning":{"publicId":"3202524","version":"1","preferredName":"N0 (i+) Stage Finding","longName":"3202524","preferredDefinition":"A regional lymph node TNM finding indicating that there are malignant cells in regional lymph node(s) no greater than 0.2 mm and are detected by hematoxylin and eosin stain or immunohistochemistry.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pN0 (i+) TNM Finding","conceptCode":"C95922","definition":"A regional lymph node TNM finding indicating that there are malignant cells in regional lymph node(s) no greater than 0.2 mm and are detected by hematoxylin and eosin stain or immunohistochemistry.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4AA8-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9DB0-642A-E040-BB89AD435F64","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N0 (i-)","valueDescription":"N0 (i-) Stage Finding","ValueMeaning":{"publicId":"3202525","version":"1","preferredName":"N0 (i-) Stage Finding","longName":"3202525","preferredDefinition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically, and immunohistochemistry is negative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pN0 (i-) TNM Finding","conceptCode":"C95921","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically, and immunohistochemistry is negative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4ACD-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9DBA-642A-E040-BB89AD435F64","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N0 (mol+)","valueDescription":"N0 (mol+) Stage Finding","ValueMeaning":{"publicId":"3202522","version":"1","preferredName":"N0 (mol+) Stage Finding","longName":"3202522","preferredDefinition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically and by immunohistochemistry, but the molecular analysis (RT-PCR) is positive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pN0 (mol+) TNM Finding","conceptCode":"C95925","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically and by immunohistochemistry, but the molecular analysis (RT-PCR) is positive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4A5E-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9DC4-642A-E040-BB89AD435F64","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N0 (mol-)","valueDescription":"N0 (mol-) Stage Finding","ValueMeaning":{"publicId":"3202523","version":"1","preferredName":"N0 (mol-) Stage Finding","longName":"3202523","preferredDefinition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically and molecular analysis (RT-PCR) is negative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pN0 (mol-) TNM Finding","conceptCode":"C95923","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically and molecular analysis (RT-PCR) is negative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4A83-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9DCE-642A-E040-BB89AD435F64","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N1","valueDescription":"N1 Stage Finding","ValueMeaning":{"publicId":"3202491","version":"1","preferredName":"N1 Stage Finding","longName":"3202491","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1 TNM Finding","conceptCode":"C48706","definition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0D1A-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9DD8-642A-E040-BB89AD435F64","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N1a","valueDescription":"N1a Stage Finding","ValueMeaning":{"publicId":"3202492","version":"1","preferredName":"N1a Stage Finding","longName":"3202492","preferredDefinition":"Breast cancer with metastasis in 1 to 3 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm). (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1a TNM Finding v6 and v7","conceptCode":"C48998","definition":"Breast cancer with metastasis in 1 to 3 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm). (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0D3F-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9DE2-642A-E040-BB89AD435F64","beginDate":"2010-04-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N1b","valueDescription":"N1b Stage Finding","ValueMeaning":{"publicId":"3202493","version":"1","preferredName":"N1b Stage Finding","longName":"3202493","preferredDefinition":"Breast cancer with metastasis in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1b TNM Finding v6","conceptCode":"C48999","definition":"Breast cancer with metastasis in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent. (from AJCC 6th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0D64-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9DEC-642A-E040-BB89AD435F64","beginDate":"2010-04-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N1bI","valueDescription":"N1bI Stage Finding","ValueMeaning":{"publicId":"3202521","version":"1","preferredName":"N1bI Stage Finding","longName":"3202521","preferredDefinition":"A regional lymph node TNM finding indicating that there is metastasis to 1-3 nodes.  The metastasis is greater than 2 mm and all are less than 20 mm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1bI Stage Finding","conceptCode":"C95929","definition":"A regional lymph node TNM finding indicating that there is metastasis to 1-3 nodes.  The metastasis is greater than 2 mm and all are less than 20 mm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4A39-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9DF6-642A-E040-BB89AD435F64","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N1bII","valueDescription":"N1bII Stage Finding","ValueMeaning":{"publicId":"3202520","version":"1","preferredName":"N1bII Stage Finding","longName":"3202520","preferredDefinition":"A regional lymph node TNM finding indicating that there is metastasis to four or more nodes.  The metastasis is greater than 2 mm and all are less than 20 mm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1bII Stage Finding","conceptCode":"C95935","definition":"A regional lymph node TNM finding indicating that there is metastasis to four or more nodes.  The metastasis is greater than 2 mm and all are less than 20 mm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4A14-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E00-642A-E040-BB89AD435F64","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N1bIII","valueDescription":"N1bIII Stage Finding","ValueMeaning":{"publicId":"3202519","version":"1","preferredName":"N1bIII Stage Finding","longName":"3202519","preferredDefinition":"A regional lymph node TNM finding indicating that the tumor extends beyond the lymph node capsule and is less than 20 mm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1bIII Stage Finding","conceptCode":"C95936","definition":"A regional lymph node TNM finding indicating that the tumor extends beyond the lymph node capsule and is less than 20 mm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-49EF-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E0A-642A-E040-BB89AD435F64","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N1bIV","valueDescription":"N1bIV Stage Finding","ValueMeaning":{"publicId":"3202518","version":"1","preferredName":"N1bIV Stage Finding","longName":"3202518","preferredDefinition":"A regional lymph node TNM finding indicating that the metastases to the lymph nodes are more than 20 mm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1bIV Stage Finding","conceptCode":"C95937","definition":"A regional lymph node TNM finding indicating that the metastases to the lymph nodes are more than 20 mm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-49CA-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E14-642A-E040-BB89AD435F64","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N1c","valueDescription":"N1c Stage Finding","ValueMeaning":{"publicId":"3202494","version":"1","preferredName":"N1c Stage Finding","longName":"3202494","preferredDefinition":"Breast cancer with metastasis in 1 to 3 axillary lymph nodes and in internal mammary nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1c TNM Finding v6","conceptCode":"C49000","definition":"Breast cancer with metastasis in 1 to 3 axillary lymph nodes and in internal mammary nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent. (from AJCC 6th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0D89-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E1E-642A-E040-BB89AD435F64","beginDate":"2010-04-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N1mi","valueDescription":"N1mi Stage Finding","ValueMeaning":{"publicId":"3202517","version":"1","preferredName":"N1mi Stage Finding","longName":"3202517","preferredDefinition":"Breast cancer with micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm) (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1mi TNM Finding v7","conceptCode":"C88353","definition":"Breast cancer with micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm) (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-49A5-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E28-642A-E040-BB89AD435F64","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N2","valueDescription":"N2 Stage Finding","ValueMeaning":{"publicId":"3202495","version":"1","preferredName":"N2 Stage Finding","longName":"3202495","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes. The definition of N2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4-9 axillary lymph nodes; for cutaneous melanoma it refers to metastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4 or more regional lymph nodes; and for bladder cancer it refers to metastases in multiple regional lymph nodes in the true pelvis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N2 TNM Finding","conceptCode":"C48786","definition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes. The definition of N2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4-9 axillary lymph nodes; for cutaneous melanoma it refers to metastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4 or more regional lymph nodes; and for bladder cancer it refers to metastases in multiple regional lymph nodes in the true pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0DAC-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E32-642A-E040-BB89AD435F64","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N2a","valueDescription":"N2a Stage Finding","ValueMeaning":{"publicId":"3202496","version":"1","preferredName":"N2a Stage Finding","longName":"3202496","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm); for cutaneous melanoma it refers to micrometastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4-6 regional lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N2a TNM Finding","conceptCode":"C48711","definition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm); for cutaneous melanoma it refers to micrometastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4-6 regional lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0DD1-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E3C-642A-E040-BB89AD435F64","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N2b","valueDescription":"N2b Stage Finding","ValueMeaning":{"publicId":"3202497","version":"1","preferredName":"N2b Stage Finding","longName":"3202497","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases only in clinically detected ipsilateral internal mammary nodes and in the absence of clinically evident level I, II axillary lymph node metastases; for cutaneous melanoma it refers to macrometastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in seven or more regional lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N2b TNM Finding","conceptCode":"C48712","definition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases only in clinically detected ipsilateral internal mammary nodes and in the absence of clinically evident level I, II axillary lymph node metastases; for cutaneous melanoma it refers to macrometastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in seven or more regional lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0DF6-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E46-642A-E040-BB89AD435F64","beginDate":"2010-04-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N2c","valueDescription":"N2c Stage Finding","ValueMeaning":{"publicId":"3342463","version":"1","preferredName":"N2c Stage Finding","longName":"3342463","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2c TNM finding depends on the specific type of cancer that it refers to; for example, for cutaneous melanoma it refers to intralymphatic metastases (in transit or satellite metastases) without metastatic nodes; for lip and oral cavity cancer it refers to metastases in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N2c TNM Finding","conceptCode":"C48713","definition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2c TNM finding depends on the specific type of cancer that it refers to; for example, for cutaneous melanoma it refers to intralymphatic metastases (in transit or satellite metastases) without metastatic nodes; for lip and oral cavity cancer it refers to metastases in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5A4E919-D7F6-0005-E040-BB89AD430ABD","latestVersionIndicator":"Yes","beginDate":"2012-01-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E50-642A-E040-BB89AD435F64","beginDate":"2012-01-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N3","valueDescription":"N3 Stage Finding","ValueMeaning":{"publicId":"3202498","version":"1","preferredName":"N3 Stage Finding","longName":"3202498","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N3 TNM Finding","conceptCode":"C48714","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0E19-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E5A-642A-E040-BB89AD435F64","beginDate":"2010-04-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N3a","valueDescription":"N3a Stage Finding","ValueMeaning":{"publicId":"3202499","version":"1","preferredName":"N3a Stage Finding","longName":"3202499","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes.  The definition of N3a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes (at least one tumor deposit greater than 2.0 mm) or metastases to the infraclavicular (level III axillary) lymph nodes; for gastric cancer it refers to metastases in 7-15 regional lymph nodes; for nasopharyngeal cancer it refers to metastases to one or more lymph nodes greater than 6 cm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N3a TNM Finding","conceptCode":"C48715","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes.  The definition of N3a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes (at least one tumor deposit greater than 2.0 mm) or metastases to the infraclavicular (level III axillary) lymph nodes; for gastric cancer it refers to metastases in 7-15 regional lymph nodes; for nasopharyngeal cancer it refers to metastases to one or more lymph nodes greater than 6 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0E3E-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E64-642A-E040-BB89AD435F64","beginDate":"2010-04-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N3b","valueDescription":"N3b Stage Finding","ValueMeaning":{"publicId":"3202500","version":"1","preferredName":"N3b Stage Finding","longName":"3202500","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes.  The definition of N3b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in clinically detected ipsilateral internal mammary lymph nodes in the presence of  one or more positive axillary lymph nodes, or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected; for gastric cancer it refers to metastases in sixteen or more regional lymph nodes; for nasopharyngeal cancer it refers to extension to the supraclavicular fossa.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N3b TNM Finding","conceptCode":"C48716","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes.  The definition of N3b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in clinically detected ipsilateral internal mammary lymph nodes in the presence of one or more positive axillary lymph nodes, or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected; for gastric cancer it refers to metastases in sixteen or more regional lymph nodes; for nasopharyngeal cancer it refers to extension to the supraclavicular fossa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0E63-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E6E-642A-E040-BB89AD435F64","beginDate":"2010-04-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N3c","valueDescription":"N3c Stage Finding","ValueMeaning":{"publicId":"3202501","version":"1","preferredName":"N3c Stage Finding","longName":"3202501","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes.  The definition of N3c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in ipsilateral supraclavicular lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N3c TNM Finding","conceptCode":"C48717","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes.  The definition of N3c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in ipsilateral supraclavicular lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0E88-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E78-642A-E040-BB89AD435F64","beginDate":"2010-04-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"N4","valueDescription":"N4 Stage Finding","ValueMeaning":{"publicId":"3205589","version":"1","preferredName":"N4 Stage Finding","longName":"3205589","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N4 TNM finding depends on the specific type of cancer that it refers to; for example, for ocular adnexal lymphoma it refers to metastases to central lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N4 TNM Finding","conceptCode":"C96026","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N4 TNM finding depends on the specific type of cancer that it refers to; for example, for ocular adnexal lymphoma it refers to metastases to central lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EC7C422-8D9A-F497-E040-BB89AD43417A","latestVersionIndicator":"Yes","beginDate":"2011-03-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E82-642A-E040-BB89AD435F64","beginDate":"2011-03-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"NX","valueDescription":"NX Stage Finding","ValueMeaning":{"publicId":"3202502","version":"1","preferredName":"NX Stage Finding","longName":"3202502","preferredDefinition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0EAB-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1D8FA6-9E8C-642A-E040-BB89AD435F64","beginDate":"2010-04-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10E57F2B-843B-55B9-E063-731AD00AE02F","beginDate":"2024-02-08","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-08","modifiedBy":"SOKKERL","dateModified":"2024-02-08","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10E57F2B-843C-55B9-E063-731AD00AE02F","beginDate":"2024-02-08","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-08","modifiedBy":"SOKKERL","dateModified":"2024-02-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3440301","version":"1","preferredName":"American Joint Committee on Cancer Clinical N Stage Stage","preferredDefinition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C39315:C25398:C25580:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE1D8FA6-9EC1-642A-E040-BB89AD435F64","latestVersionIndicator":"Yes","beginDate":"2012-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE1D8FA6-9D8E-642A-E040-BB89AD435F64","latestVersionIndicator":"Yes","beginDate":"2012-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"SOKKERL","dateModified":"2024-02-08","changeDescription":"Created for and approved by TCGA per T.Lichtenberg. mc 4/23/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"13574489","version":"1","longName":"Childhood Cancer Data Initiative","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"13594093","version":"1","longName":"Sample","context":"Pediatric Cancer"},{"publicId":"13596043","version":"1","longName":"Sample","context":"Pediatric Cancer"},{"publicId":"13596241","version":"1","longName":"Diagnosis","context":"Pediatric Cancer"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787505","version":"1","longName":"HNSC","context":"NCIP"},{"publicId":"3787508","version":"1","longName":"KIRP","context":"NCIP"},{"publicId":"3787513","version":"1","longName":"LUSC","context":"NCIP"},{"publicId":"3787514","version":"1","longName":"OV","context":"NCIP"},{"publicId":"3787516","version":"1","longName":"PRAD","context":"NCIP"},{"publicId":"3787502","version":"1","longName":"CESC","context":"NCIP"},{"publicId":"3787503","version":"1","longName":"COAD","context":"NCIP"},{"publicId":"3787506","version":"1","longName":"KICH","context":"NCIP"},{"publicId":"3787507","version":"1","longName":"KIRC","context":"NCIP"},{"publicId":"3787499","version":"1","longName":"BLCA","context":"NCIP"},{"publicId":"3787500","version":"1","longName":"BRCA","context":"NCIP"},{"publicId":"3787511","version":"1","longName":"LIHC","context":"NCIP"},{"publicId":"3787519","version":"1","longName":"SKCM","context":"NCIP"},{"publicId":"3787512","version":"1","longName":"LUAD","context":"NCIP"},{"publicId":"3787517","version":"1","longName":"READ","context":"NCIP"},{"publicId":"3787520","version":"1","longName":"STAD","context":"NCIP"},{"publicId":"3787522","version":"1","longName":"UCEC","context":"NCIP"},{"publicId":"3787521","version":"1","longName":"THCA","context":"NCIP"},{"publicId":"3787515","version":"1","longName":"PAAD","context":"NCIP"}]},{"publicId":"8064110","version":"1","longName":"CDS (Cancer Data Service)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"12177497","version":"1","longName":"Diagnosis","context":"CRDC"},{"publicId":"14470388","version":"1","longName":"Imaging","context":"CRDC"}]}],"AlternateNames":[{"name":"clinical_N","type":"TCGA_XML_Name","context":"NCIP"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"OTH_TUMOR_C_N_STG","type":"COG GDE Short Name","context":"COG"},{"name":"3440200v1.0:3440297v1.0","type":"USED_BY","context":"DCP"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"tumor_stage_clinical_n","type":"CDS Alt Name","context":"CRDC"},{"name":"tumor_stage_clinical_n","type":"CCDI Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"Generic CDE for TCGA","type":"NOTE","description":"This generic element includes N stage values from multiple editions of AJCC as provided by The Cancer Genome Atlas (TCGA).","url":null,"context":"NCIP"},{"name":"Clinical N Stage","type":"Preferred Question Text","description":"Clinical N Stage","url":null,"context":"NCIP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"TNM Staging: Clinical N Stage","url":null,"context":"COG"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE1E2E88-6A04-177F-E040-BB89AD431745","latestVersionIndicator":"Yes","beginDate":"2012-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"JKNABLE","dateModified":"2023-12-31","changeDescription":"3/1/22 jk Designated, added CDS alt name and CSI. ---  Created and released for TCGA per approval by T.Lichtenberg. mc 4/23/12","administrativeNotes":"12/31/23 Added CDS Imaging CSI. jk;  1/23/23 Removed general CDS CSI, added Diagnosis. Per CDS metadata template. mr;","unresolvedIssues":null,"deletedIndicator":"No"}}